Table 1 Clinical and ultrasound imaging features of patients in overall study population, HT and No-HT group
Variables | Overall study population (n = 198) | HT (n = 82) | No-HT (n = 116) | p |
|---|---|---|---|---|
Gender | 0.048 | |||
Male | 38 (19.2%) | 9 (11.0%) | 29 (25.0%) | |
Female | 160 (80.8%) | 73 (89.0%) | 87 (75.0%) | |
Age (years) | ||||
Median (interquartile range) | 34.0 (29.0–40.0) | 34.0 (30.0–40.0) | 34.5 (28.0–41.0) | 0.854 |
≤ 35 | 109 (55.1%) | 44 (53.7%) | 65 (56.0%) | 0.947 |
> 35 | 89 (44.9%) | 38 (46.3%) | 51 (44.0%) | |
Thyroid gland size (mm) | ||||
Vertical diameter | 51.0 (47.0–55.0) | 52.5 (48.0–56.0) | 50.0 (46.0–54.0) | 0.018 |
Transverse diameter | 16.0 (14.0–18.0) | 17.0 (15.0–18.0) | 15.5 (13.8–17.0) | 0.014 |
Anteroposterior diameter | 14.0 (12.0–15.0) | 14.0 (13.0–16.0) | 13.0 (12.0–14.0) | < 0.001 |
Thyroid nodule position | 0.251 | |||
Left lobe | 96 (48.5%) | 34 (41.5%) | 62 (53.4%) | |
Right lobe | 102 (51.5%) | 48 (58.5%) | 54 (46.6%) | |
Thyroid nodule quantity | 0.993 | |||
Single | 144 (72.7%) | 60 (73.2%) | 84 (72.4%) | |
Multiple | 54 (27.3%) | 22 (26.8%) | 32 (27.6%) | |
Thyroid nodule size (mm) | ||||
Vertical diameter | 11.0 (7.3–17.0) | 12.0 (7.4–17.8) | 10.5 (7.1–15.0) | 0.356 |
Transverse diameter | 9.0 (6.3–13.0) | 9.0 (6.3–14.0) | 9.0 (6.3–12.0) | 0.835 |
Anteroposterior diameter | 8.6 (6.0–11.3) | 8.7 (5.9–12.0) | 8.4 (6.0–11.0) | 0.863 |
TPOAb (IU/ml) | 12.2 (8.4–23.2) | 10.0 (8.0–13.1) | 33.3 (10.6–127.0) | < 0.001 |
TgAb (IU/ml) | 13.5 (10.0–131.4) | 10.0 (10.0–13.2) | 176.4 (42.0–368.7) | < 0.001 |
TPOAb positivity | 39 (20.3%) | 38 (48.1%) | 1 (0.9%) | < 0.001 |
TgAb positivity | 50 (25.5%) | 50 (61.7%) | 0 (0.0%) | < 0.001 |